NCT03084445

Brief Summary

Objectives and hypothesis The scale and diversity of chemicals in worldwide use today is vast. Many of these chemicals are released into the environment where they are found in air, water, soil, house dust, and in the food supply, resulting in exposure to humans. Characterizing the extent of exposure and the effects of exposure in vulnerable populations, such as pregnant women and children, is of the utmost importance as the chemical structure of many of these compounds resembles hormones such as estrogen, testosterone and thyroid hormone, affect neurodevelopment and other health effects. Here, we focus on few classes of compounds: heavy metals, volatile organic compounds (VOCs), brominated flame retardants (PBDEs) and phthalates. We will characterize the extent of exposure to pregnant women and their infants in Israel, where biomonitoring studies in the general population are scarce. We will also examine selected outcomes in pregnant women and their offspring in relation to these compounds, and to establish a biorepository for further studies. Specific Aims:

  1. 1.To assess Heavy metals, VOCs, PBDEs and phthalates body burdens through measurement of these chemicals in maternal and paternal serum and urine, cord blood, breastmilk and neonatal meconium among several representative sub-populations.
  2. 2.To examine associations between exposure to heavy metals, VOCs, PBDEs and phthalates and (a) pregnancy complications, (b) anthropometrics at birth (i.e. birth weight adjusted for gestational age, ponderal index, head circumference adjusted for gestational age), and (c) cryptorchidism incidence, (d) maternal and infant thyroid function.
  3. 3.To establish a bio repository of these media for future studies and to establish follow up methods for this cohort to later assess development and growth in the infants, toddlers and children.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,394

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2013

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2014

Completed
3.1 years until next milestone

First Posted

Study publicly available on registry

March 21, 2017

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
5.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 31, 2024

Status Verified

July 1, 2024

Enrollment Period

6.8 years

First QC Date

February 6, 2014

Last Update Submit

July 30, 2024

Conditions

Keywords

Brominated Flame Retardants (BFRs)Phthalatespregnant womennewbornHeavy MetalsVolatile Organic Compounds

Outcome Measures

Primary Outcomes (1)

  • Measuring envinromental polutants, including heavy metals, VOCs, PBDEs and phthalates levels in collected samples

    assessment of BFRs and phthalates body burdens through measurement of these chemicals in maternal and paternal serum and urine, cord blood, breastmilk and neonatal meconium among several representative sub-populations

    48 months after end of specimens collection

Secondary Outcomes (1)

  • associations between exposure to nvinromental polutants, including heavy metals, VOCs, PBDEs and phthalates and few maternal and infant pregnancy and birth parameters and endocrine functions

    48 months after end of specimens collection

Other Outcomes (1)

  • To establish a bio repository of these media for future studies

    15 years after end of specimens collection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women and their partners attenting delivery room

You may qualify if:

  • Israeli Arabs, Jews from Russia, Jews from Ethiopia, Jews with an Ashkenazic background and Jews with a Sephardic background

You may not qualify if:

  • refuse to take part in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Rambam Medical Center

Haifa, Israel

Location

Lis Medical Center

Tel Aviv, Israel

Location

Assaf Harofeh Medical Center

Ẕerifin, 70300, Israel

Location

Biospecimen

Retention: SAMPLES WITH DNA

whole blood, serum, white cells, red blood cells, urine, breast milk, meconium

Study Officials

  • Mati Berkovitch, Prof.

    Assaf-Harofeh Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
3 Days
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2014

First Posted

March 21, 2017

Study Start

September 1, 2013

Primary Completion

June 1, 2020

Study Completion

December 31, 2025

Last Updated

July 31, 2024

Record last verified: 2024-07

Locations